Brain TB Scans Mislead Doctors: Unnecessary Treatment Feared

A study involving 201 patients found that nearly half of those treated for brain tuberculosis continued medication despite showing no active disease. Persistent abnormalities on MRI scans, which can represent scar tissue or inflammation rather than active infection, often lead to prolonged treatment. This practice is being questioned by researchers who advocate for decisions on treatment cessation to be based on a combination of factors, including symptoms and neurological condition, not just scan results.

Researchers noted that while most patients improve, MRI scans might still show lesions post-treatment. In 41% of cases, lesions remained visible, while in 35%, they disappeared. Paradoxical reactions, where lesions appear to worsen during treatment, were observed in 47% of patients but are often a normal immune response. The study highlighted that treatment often extended beyond one or even two years due to these persistent scan findings. Relapse of the infection was uncommon, occurring in only 3.5% of patients.

Experts stress that residual lesions could be due to inflammation, swelling, or scar tissue, not necessarily active TB. They recommend doctors consider symptoms, neurological status, and scan changes over time. However, they caution that patients with worsening symptoms or suspected drug-resistant TB require individualized care. Further research is needed to establish definitive guidelines for discontinuing treatment in clinically recovered patients with residual MRI abnormalities.